Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma
Cited by 20
Related Papers
GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer
|Signal Transduction and Targeted Therapy|2023|43
Author Correction: GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer
|Signal Transduction and Targeted Therapy|2023|1